Urology products
CamStent’s unique polymer coating resists attachment of the organisms that create biofilms, preventing patients from developing infections and protecting against tissue damage.
25% of all hospital admissions use urinary catherization to assure bladder drainage. Currently the catheter surface promotes the growth of bacterial biofilms, often leading to inflammation and infection. Catheter Acquired Urinary Tract Infections (CAUTI) develop quickly after insertion, and are the major class of hospital acquired infections today, according to both the NHS and CDC. The added cost of treating these infections is estimated to be over £100 million a year due to the combination of medication and an average of six days of additional hospitalization.
CamStent has developed a biofilm-reistant catheter coating with PEG sidechains that resist attachment of the organisms implicated in Urinary Tract Infections. It offers unique advantages over current products:
- Giving superior resistance to biofilm development and encrustation.
- Forming a smooth, thin surface over the catheter that minimizes patient discomfort and chronic irritation, yet remaining bonded to the catheter throughout normal use.
-
Being non-pharmacologic, it also avoids excess appliction of antibiotics and possible emergence of drug-resistant strains of pathological organisms.
-
10.12.2009
CamStent launches website
Read more...As part of our commitment to quality, we updated our website so we can give better information about our company and the projects we're working on. Let us know what you think.
- About CamStent
- Technology
- Meet the team
-
